Health Care
  • Dow 13,000-Another Case of Irrational Exuberance?

    By Caroline Valetkevitch, Reuters

    If upcoming earnings from U.S. retailers are as unimpressive as the rest of the profit season has been, Wall Street could face a tough time justifying a stock market at nine-month highs.

  • What Those New Super Drugs Really Cost

    By Merrill Goozner, The Fiscal Times

    The drug industry usually defends the high price on drugs – the latest cancer therapies are tipping the scales at $100,000 a year – by pointing to the large sums it spends on research and development...

  • Consumers Get Help on Health Insurance Plans

    By Susan Jaffe, Kaiser Health News

    The Obama administration Thursday unveiled final regulations detailing the new health insurance summaries that the federal health law requires plans to give to consumers to help them make informed...

  • Out-of-Network Outrage: Soaring Health Costs

    By Julie Appleby, Kaiser Health News

    A growing number of insurers have changed the way they calculate reimbursements to shift more of the expense to patients. Now, instead of paying a percentage of the "usual and customary" charges from...

  • In the Pink: 11 Surprising Komen Branded Products

    Susan G. Komen for the Cure has made the pink ribbon a ubiquitous symbol of breast cancer awareness – and has put its signature color on an incredibly wide range of other products too.